195 related articles for article (PubMed ID: 6488171)
21. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
22. Antitumor activity of Corynebacterium parvum extracts.
McBride WH; Dawes J; Tuach S
J Natl Cancer Inst; 1976 Feb; 56(2):437-9. PubMed ID: 1255777
[TBL] [Abstract][Full Text] [Related]
23. Protection by polyI:polyC against infection with herpes simplex virus in mice pretreated with Corynebacterium parvum.
Storch E; Baumgartl D; Kirchner H
Nat Immun Cell Growth Regul; 1983-1984; 3(3):134-42. PubMed ID: 6209572
[TBL] [Abstract][Full Text] [Related]
24. Stimulation of the respiratory burst of murine peritoneal inflammatory neutrophils by conjugation with tumor cells.
Lichtenstein A
Cancer Res; 1987 May; 47(9):2211-7. PubMed ID: 3032419
[TBL] [Abstract][Full Text] [Related]
25. Attempts to correlate interferon induction and activation of natural killer cells by Corynebacterium parvum.
Chmielarczyk W; Kirchner H; Ernst R; Storch E
Immunobiology; 1985 May; 169(4):403-11. PubMed ID: 2408996
[TBL] [Abstract][Full Text] [Related]
26. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
Yuhas JM; Ullrich RL
Cancer Res; 1976 Jan; 36(1):161-6. PubMed ID: 1247995
[TBL] [Abstract][Full Text] [Related]
27. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
Tomecki J; Mara M
Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
[TBL] [Abstract][Full Text] [Related]
28. Effects of dose and schedule of immune stimulant on efficacy of combination Corynebacterium parvum-cyclophosphamide treatment for a murine mammary adenocarcinoma.
Purnell DM; Bartlett GL; Kreider JW
Cancer Res; 1979 Jan; 39(1):1-5. PubMed ID: 761179
[TBL] [Abstract][Full Text] [Related]
29. Evidence for granulocyte-mediated macrophage activation after C. parvum immunization.
Chapes SK; Haskill S
Cell Immunol; 1983 Feb; 75(2):367-77. PubMed ID: 6831566
[TBL] [Abstract][Full Text] [Related]
30. Enhanced resistance of mice to Mycoplasma pulmonis-induced arthritis by administration of killed Corynebacterium parvum.
Keystone EC; Taylor-Robinson D; Ling L; Pope C; Metcalfe A; Furr P; Fornasier V
Clin Exp Immunol; 1981 Nov; 46(2):355-62. PubMed ID: 7337973
[TBL] [Abstract][Full Text] [Related]
31. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor effect of Corynebacterium parvum].
Mazurek C; Chalvet H; Biozzi G; Stiffel C
Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
[TBL] [Abstract][Full Text] [Related]
33. Contribution of complement-stimulated hepatic macrophages and neutrophils to endotoxin-induced liver injury in rats.
Jaeschke H; Farhood A; Smith CW
Hepatology; 1994 Apr; 19(4):973-9. PubMed ID: 8138272
[TBL] [Abstract][Full Text] [Related]
34. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
35. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
Ansell JD; Trail KN; McDougall CM; Inchley CJ
J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
[TBL] [Abstract][Full Text] [Related]
36. Eradication of ovarian tumor xenografts by locoregional administration of targeted immunotherapy.
De Cesare M; Calcaterra C; Pratesi G; Gatti L; Zunino F; Mènard S; Balsari A
Clin Cancer Res; 2008 Sep; 14(17):5512-8. PubMed ID: 18765543
[TBL] [Abstract][Full Text] [Related]
37. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
[TBL] [Abstract][Full Text] [Related]
38. Studies on antitumor effect of corynebacterium parvum and pustulan on Lewis lung carcinoma in mice.
Budzyński W
Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):379-84. PubMed ID: 7184489
[TBL] [Abstract][Full Text] [Related]
39. Macrophage functions in beige (Chédiak-Higashi syndrome) mice.
Mahoney KH; Morse SS; Morahan PS
Cancer Res; 1980 Nov; 40(11):3934-9. PubMed ID: 7471044
[TBL] [Abstract][Full Text] [Related]
40. Immunomodulation by corynebacterium parvum in two strains of guinea-pigs and the effect of cyclophosphamide.
Gauthier-Rahman S
Immunology; 1981 Jan; 42(1):99-109. PubMed ID: 7461727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
